| Name | Title | Contact Details |
|---|
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
A.T. Radiology is a diagnostic imaging provider with locations in Winter Haven, Davenport, and Lake Wales, Florida. They provide exceptional radiology and diagnostic services for patients and referring physicians throughout Florida.
Busse Hospital Disposables is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
VCA Antech, Inc. (VCA) is an animal healthcare company operating in the United States and Canada.
Diamond Recovery Centers is run by members in recovery, industry-leading professionals, and world-class clinicians. Our mission statement is ” If we put the clients and their needs first, everything else will fall in place”. Our only goal is to help those struggling with Mental Health and Substance Abuse one client at a time.